Modification of British committee for standards in haematology diagnostic criteria for essential thrombocythaemia

Modification of British committee for standards in haematology diagnostic criteria for essential thrombocythaemia

Show other versions (1)

Bibliographic Details
Main Authors:	Harrison, C, Butt, N, Campbell, P, Conneally, E, Drummond, M, Green, A, Murrin, R, Radia, D, Mead, A, Reilly, J, Cross, N, Mcmullin, M
Format:	Journal article
Language:	English
Published:	Blackwell Publishing Ltd 2014

Similar Items

Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia.
by: Harrison, C, et al.
Published: (2014)

Use of JAK inhibitors in the management of myelofibrosis: A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012
by: Reilly, J, et al.
Published: (2014)

Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.
by: Reilly, J, et al.
Published: (2014)

Shared care protocol for the management of essential thrombocythaemia patients in primary care
by: Sweeney, C, et al.
Published: (2011)

Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value.
by: Harrison, C, et al.
Published: (1999)

Equivalence of BCSH and WHO diagnostic criteria for ET
by: Harrison, C, et al.
Published: (2016)

Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline
by: McLornan, DP, et al.
Published: (2023)

A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK
by: Harrison, C, et al.
Published: (2019)

Ruxolitinib compared with best available therapy for essential thrombocythaemia patients resistant or intolerant to hydroxycarbamide in majic: an investigator lead randomized trial
by: Harrison, C, et al.
Published: (2016)

Disease progression in patients with essential thrombocythaemia receiving anagrelide within a single institution
by: Gray, N, et al.
Published: (2020)

A guideline for the diagnosis and management of polycythaemia vera. A British Society for haematology guideline
by: McMullin, M, et al.
Published: (2018)

Hydroxycarbamide plus Aspirin vs Aspirin alone in patients with essential Thrombocythaemia aged 40-59 years without high-risk features
by: Buck, G, et al.
Published: (2018)

Patient self-testing and self-management of oral anticoagulation with vitamin K antagonists: guidance from the British Committee for Standards in Haematology.
by: Jennings, I, et al.
Published: (2014)

Impact of platelet glycoprotein polymorphisms upon clinical events in essential thrombocythaemia patients enrolled in the PT1 trial
by: Robinson, SE, et al.
Published: (2007)

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.
by: Campbell, P, et al.
Published: (2005)

The need for diagnostic criteria in systemic vasculitis
by: Suppiah, R, et al.
Published: (2011)

Diagnostic criteria for vascular dementia
by: Amar, K, et al.
Published: (1996)

Haematological Disease
by: Murphy, M, et al.
Published: (2009)

Haematological Disease
by: Estcourt, L, et al.
Published: (2013)

Practical haematology /
by: 344140 Dacie, John Vivian
Published: (1975)

Haematological parameters and anaemia in white and British Indian meat-eaters and vegetarians in UK Biobank
by: Tong, T, et al.
Published: (2019)

British Association for Irish Studies (Interim Committee)
by: British Association for Irish Studies, BAIS, et al.
Published: (1986)

British Association for Irish Studies (interim committee)
by: British Association for Irish Studies, BAIS
Published: (1986)

Prioritisation criteria for the selection of new diagnostic technologies for evaluation.
by: Plüddemann, A, et al.
Published: (2010)

A proposal for new diagnostic criteria for ALS
by: Shefner, JM, et al.
Published: (2020)

Haematology of Down syndrome.
by: Webb, D, et al.
Published: (2007)

The future of academic haematology
by: Hay, D, et al.
Published: (2016)

The use of viscoelastic haemostatic assays in the management of major bleeding: A British Society for Haematology Guideline
by: Curry, NS, et al.
Published: (2018)

Primary lateral sclerosis: consensus diagnostic criteria
by: Turner, MR, et al.
Published: (2020)

Depression in dementia sufferers--comparison of diagnostic criteria.
by: Ballard, C, et al.
Published: (1997)

Recommended diagnostic criteria for paraneoplastic neurological syndromes.
by: Graus, F, et al.
Published: (2004)

Towards diagnostic criteria for the ANCA-associated vasculitides.
by: Luqmani, R
Published: (2007)

Ruxolitinib induces changes in histone modification status in patients entered into the MAJIC clinical trial
by: McPherson, S, et al.
Published: (2018)

Modification of the histone landscape with JAK inhibition in myeloproliferative neoplasms
by: Greenfield, G, et al.
Published: (2020)

Diagnostic criteria for major depressive disorder in cancer patients: A review
by: Guan, N.C., et al.
Published: (2013)

The expression of phosphorylated KDR in haematological malignancies
by: Pillai, G, et al.
Published: (2003)

Immunotherapy and immunomodulation for haematological malignancies
by: Mussai, F, et al.
Published: (2012)

T cell disorders in haematological diseases.
by: Catovsky, D, et al.
Published: (1982)

The genesis of paediatric haematology in the UK
by: Roberts, I, et al.
Published: (2020)

Clinical haematology in medical practice /
by: 344297 De Gruchy, Gordon Carle
Published: (1970)